Nov Inc
NYSE:NOV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
14.06
21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Nov Inc
Wall Street
Price Targets
NOV Price Targets Summary
Nov Inc
According to Wall Street analysts, the average 1-year price target for
NOV
is 20.35 USD
with a low forecast of 12.12 USD and a high forecast of 27.3 USD.
NOV Last Price Targets
Nov Inc
The latest public price target was made on Oct 11, 2024 by
Stephen Gengaro
from
Stifel Nicolaus
,
who expects
NOV
stock to
rise by 78%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Stephen Gengaro
Stifel Nicolaus
|
25
USD
Upside 78% |
2 months ago
Oct 11, 2024
|
NOV Inc. price target lowered to $25 from $26 at Stifel
TheFly
|
Phillip Jungwirth
BMO Capital
|
20
USD
Upside 42% |
2 months ago
Oct 10, 2024
|
NOV Inc. price target lowered to $20 from $22 at BMO Capital
TheFly
|
Daniel Kutz
Morgan Stanley
|
23
USD
Upside 63% |
3 months ago
Sep 16, 2024
|
NOV Inc. price target lowered to $23 from $25 at Morgan Stanley
TheFly
|
David Anderson
Barclays
|
20
USD
Upside 42% |
4 months ago
Jul 30, 2024
|
NOV Inc. price target raised to $20 from $17 at Barclays
TheFly
|
Unknown Analyst
Susquehanna
|
29
USD
Upside 106% |
1 year ago
Feb 8, 2023
|
Susquehanna Maintains Positive on NOV, Raises Price Target to $29
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NOV's stock price target?
Price Target
20.35
USD
According to Wall Street analysts, the average 1-year price target for
NOV
is 20.35 USD
with a low forecast of 12.12 USD and a high forecast of 27.3 USD.
What is Nov Inc's Revenue forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
Nov Inc's revenue is
-7%.
The projected
CAGR
for the next 4 years is
4%.
What is Nov Inc's Operating Income forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Nov Inc's operating income is
-8%.
The projected
CAGR
for the next 3 years is
14%.
What is Nov Inc's Net Income forecast?
Projected CAGR
-6%
The
compound annual growth rate
of Nov Inc's net income for the next 4 years is
-6%.
You don't have any saved screeners yet
